Rosiglitazone augments antioxidant response in the human trophoblast and prevents apoptosis()

Insufficient perfusion of the trophoblast by maternal blood is associated with an increased generation of reactive oxygen species and complications of the placenta. In this study, we first examined whether rosiglitazone, an agonist of the peroxisome proliferator-activated receptor-γ (PPARγ), protect...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Biol Reprod
Autores principales: Kohan-Ghadr, Hamid-Reza, Kilburn, Brian A, Kadam, Leena, Johnson, Eugenia, Kolb, Bradley L, Rodriguez-Kovacs, Javier, Hertz, Michael, Armant, D Randall, Drewlo, Sascha
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2019
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6500927/
https://ncbi.nlm.nih.gov/pubmed/30137220
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/biolre/ioy186
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares